Acadia Pharmaceuticals reported $-113016000 in EBIT for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -113016000 68.36M
ALKERMES ALKS:US -34457000 7.87M
Alnylam Pharmaceuticals ALNY:US $ -191686000 44.95M
Biogen BIIB:US $ 940.9M 409.4M
Biomarin Pharmaceutical BMRN:US $ 39.15M 9.82M
Bristol Myers Squibb BMY:US $ 3197M 9M
Cara Therapeutics CARA:US $ -27911000 5.61M
Corcept Therapeutics CORT:US $ 31.43M 4.66M
Cytokinetics CYTK:US $ -10874000 66.98M
Eisai 4523:JP 7.43B 28.23B
Eli Lilly And LLY:US $ 1650.5M 919.4M
Intercept Pharmaceuticals ICPT:US $ -13363000 3.09M
Intra Cellular Therapies ITCI:US $ -72662000 13.34M
Johnson & Johnson JNJ:US $ 6941M 599M
Marinus Pharmaceuticals MRNS:US -16711000 10.4M
Moderna Inc MRNA:US 2.45B 1.78B
Neurocrine Biosciences NBIX:US $ 54.7M 51.6M
Pfizer PFE:US $ 12099M 2104M
Prothena PRTA:US -37944000 4.85M
Ptc Therapeutics PTCT:US $ -92362000 5.84M
Sarepta Therapeutics SRPT:US $ -211132000 124.25M
Seattle Genetics SGEN:US $ -133111000 61K
Ultragenyx Pharmaceutical RARE:US $ -141593000 4.96M
Vertex Pharmaceuticals VRTX:US $ 1134.8M 101.4M
YTE INCY:US $ 260.29M 132.62M